Clover Health Investments, Corp. (CLOV) Insider Trading Activity

NASDAQ$5.1+0.28 (5.81%)
Market Cap
$2.5B
Sector
Healthcare
Industry
Medical—Healthcare Plans
Rank in Sector
491 of 852
Rank in Industry
8 of 11

CLOV Insider Trading Activity

CLOV Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$5,196,583
29
100

Related Transactions

OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER
0
$0
1
$58,816
$-58,816
THORNTON JOSEPH CLAYInterim CFO
0
$0
2
$99,654
$-99,654
Edwards Carladenise Armbristerdirector
0
$0
1
$229,687
$-229,687
Soares KarenChief Legal Officer
0
$0
3
$303,870
$-303,870
Reynoso Jamie L.CEO, Medicare Advantage
0
$0
15
$418,311
$-418,311
Priest Brady PatrickCEO of Home Care
0
$0
2
$724,847
$-724,847
Wai ConradCEO, Counterpart Health
0
$0
2
$992,584
$-992,584
Toy AndrewChief Executive Officer
0
$0
3
$2.37M
$-2.37M

About Clover Health Investments, Corp.

Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.

Insider Activity of Clover Health Investments, Corp.

Over the last 12 months, insiders at Clover Health Investments, Corp. have bought $0 and sold $5.2M worth of Clover Health Investments, Corp. stock.

On average, over the past 5 years, insiders at Clover Health Investments, Corp. have bought $3.43M and sold $3.64M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 26,500 shares for transaction amount of $68,755 was made by Loengard Anna U (director) on 2025‑08‑13.

List of Insider Buy and Sell Transactions, Clover Health Investments, Corp.

2026-08-17SaleTHORNTON JOSEPH CLAYInterim CFO
17,775
0.0035%
$4.39
$78,032
-0.70%
2026-08-10SaleToy AndrewChief Executive Officer
87,798
0.017%
$4.65
$408,261
-6.78%
2026-07-20SaleSoares KarenChief Legal Officer
51,700
0.0097%
$4.51
$233,167
-4.34%
2026-07-17SaleReynoso Jamie L.CEO, Medicare Advantage
4,839
0.001%
$4.53
$21,921
-4.44%
2026-07-15SaleToy AndrewChief Executive Officer
62,711
0.0121%
$4.67
$292,860
-7.87%
2026-07-15SaleReynoso Jamie L.CEO, Medicare Advantage
13,119
0.0025%
$4.67
$61,266
-7.87%
2026-07-15SaleSoares KarenChief Legal Officer
10,519
0.002%
$4.67
$49,124
-7.87%
2026-07-15SaleTHORNTON JOSEPH CLAYInterim CFO
4,630
0.0009%
$4.67
$21,622
-7.87%
2026-07-15SaleWai ConradCEO, Counterpart Health
24,215
0.0047%
$4.67
$113,084
-7.87%
2026-07-08SaleReynoso Jamie L.CEO, Medicare Advantage
2,384
0.0005%
$4.68
$11,157
-6.87%
2026-07-06SaleReynoso Jamie L.CEO, Medicare Advantage
6,229
0.0012%
$5.26
$32,765
-13.78%
2026-07-01SaleToy AndrewChief Executive Officer
313,476
0.0614%
$5.32
$1.67M
-18.60%
2026-06-17SaleReynoso Jamie L.CEO, Medicare Advantage
2,360
0.0005%
$4.78
$11,281
-6.25%
2026-06-16SaleOLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER
12,102
0.0023%
$4.86
$58,816
-8.76%
2026-06-15SaleReynoso Jamie L.CEO, Medicare Advantage
6,350
0.0012%
$4.61
$29,274
-6.13%
2026-06-15SaleSoares KarenChief Legal Officer
4,681
0.0009%
$4.61
$21,579
-6.13%
2026-06-11SaleReynoso Jamie L.CEO, Medicare Advantage
7,289
0.0014%
$4.91
$35,789
-7.48%
2026-05-28SaleWai ConradCEO, Counterpart Health
220,426
0.0473%
$3.99
$879,500
+7.54%
2026-05-18SaleEdwards Carladenise Armbristerdirector
67,160
0.0131%
$3.42
$229,687
+29.42%
2026-05-13SalePriest Brady PatrickCEO of Clover Care Services
98,039
0.0203%
$3.52
$345,097
+22.25%
Total: 51
*Gray background shows transactions not older than one year

Insider Historical Profitability

87.29%
Toy AndrewChief Executive Officer
9459316
1.8252%
$45.59M03
Reynoso Jamie L.CEO, Medicare Advantage
2814640
0.5431%
$13.57M019
Priest Brady PatrickCEO of Clover Care Services
2040222
0.3937%
$9.83M03
Soares KarenChief Legal Officer
1505522
0.2905%
$7.26M04
THORNTON JOSEPH CLAYInterim CFO
1249526
0.2411%
$6.02M02
Wai ConradCEO, Counterpart Health
1145699
0.2211%
$5.52M05
OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER
299067
0.0577%
$1.44M01
Edwards Carladenise Armbristerdirector
285432
0.0551%
$1.38M02
Garipalli Vivek
1856247
0.3582%
$8.95M40
+78.12%
Palihapitiya Chamath10 percent owner
1739130
0.3356%
$8.38M10
<0.0001%
SHAPIRO LEE
107100
0.0207%
$516,222.0010
<0.0001%
Clinton Chelsea
100000
0.0193%
$482,000.0010
<0.0001%
Loengard Anna Udirector
29610
0.0057%
$142,720.2050
+164.23%
*Gray background shows insiders who have made transactions during last year

CLOV Institutional Investors: Active Positions

Increased Positions90+38.96%9M+6.87%
Decreased Positions91-39.39%19M-13.94%
New Positions30New791,085New
Sold Out Positions37Sold Out9MSold Out
Total Postitions230-0.43%125M-7.08%

CLOV Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$73,252.007.17%30.39M-2,049<0.01%2025-09-30
Vanguard Group Inc$55,575.005.44%23.06M-1M-4.89%2025-09-30
Geode Capital Management, Llc$23,426.002.29%9.72M-122,942-1.25%2025-09-30
State Street Corp$21,574.002.11%8.95M+1M+19.24%2025-09-30
Renaissance Technologies Llc$18,588.001.82%7.71M-3M-26.5%2025-09-30
Pnc Financial Services Group, Inc.$10,758.001.05%4.46M00%2025-09-30
Charles Schwab Investment Management Inc$10,294.001.01%4.27M+377,605+9.7%2025-09-30
Northern Trust Corp$8,129.000.8%3.37M-2,819-0.08%2025-09-30
Divisadero Street Capital Management, Lp$6,671.000.65%2.77M+3MNew2025-09-30
Susquehanna International Group, Llp$6,512.000.64%2.7M-289,857-9.69%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.